|
1
|
Steiner S and Anderson NL: Pharmaceutical
proteomics. Ann NY Acad Sci. 919:48–51. 2000. View Article : Google Scholar
|
|
2
|
Graves PR, Kwiek JJ, Fadden P, et al:
Discovery of novel targets of quinoline drugs in the human purine
binding proteome. Mol Pharmacol. 62:1364–1372. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruneau JM, Maillet J, Tagat E, et al:
Drug induced protome changes in Candida albicans: comparison
of the effect of beta(1,3) glucan synthase inhibitors and two
triazoles, fluconazole and itraconazole. Proteomics. 3:325–336.
2003.PubMed/NCBI
|
|
4
|
You QD and Lin GQ: Chiral Drugs: Research
and Application. 34. Chemical Industry Press; Beijing: pp. 230–234.
2003
|
|
5
|
Lee DH, Jacobs DR Jr, Gross M, et al:
Gamma-glutamyltransferase is a predictor of incident diabetes and
hypertension: the Coronary Artery Risk Development in Young Adults
(CARDIA) Study. Clin Chem. 49:1358–1366. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee DH, Ha MH, Kim JH, et al:
Gamma-glutamyltransferase and diabetes - a 4 years follow-up study.
Diabetologia. 46:359–364. 2003.PubMed/NCBI
|
|
7
|
Dorsch M, Danial NN, Rothman PB and Goff
SP: A thrombopoietin receptor mutant deficient in Jak-STAT
activation mediates proliferation but not differentiation in UT-7
cells. Blood. 94:2676–2685. 1999.PubMed/NCBI
|
|
8
|
Guil S, de La Iglesia N, Fernández-Larrea
J, et al: Alternative splicing of the human proto-oncogene c-H-ras
renders a new Ras family protein that trafficks to cytoplasm and
nucleus. Cancer Res. 63:5178–5187. 2003.PubMed/NCBI
|
|
9
|
Kim IS, Ryang YS, Kim YS, et al:
Leukotactin-1-induced ERK activation is mediated via Gi/Go
protein/PLC/PKC delta/Ras cascades in HOS cells. Life Sci.
73:447–459. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mochly-Rosen D, Khaner H and Lopez J:
Identification of intracellular receptor proteins for activated
protein kinase C. Proc Natl Acad Sci USA. 88:3997–4000. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mamidipudi V, Dhillon NK, Parman T, Miller
LD, Lee KC and Cartwright CA: RACK1 inhibits colonic cell growth by
regulating Src activity at cell cycle checkpoints. Oncogene.
26:2914–2924. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bolger GB, Baillie GS, Li X, et al:
Scanning peptide array analyses identify overlapping binding sites
for the signaling scaffold proteins, beta-arrestin and RACK1, in
cAMP-specific phosphodiesterase PDE4D5. Biochem J. 398:23–36. 2006.
View Article : Google Scholar
|
|
13
|
Kiely PA, O'Gorman D, Luong K, Ron D and
O'Connor R: Insulin-like growth factor I controls a mutually
exclusive association of RACK1 with protein phosphatase 2A and
beta1 integrin to promote cell migration. Mol Cell Biol.
26:4041–4051. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hermanto V, Zong CS, Li W and Wang LH:
RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting
protein, modulates IGF-I-dependent integrin signaling and promotes
cell spreading and contact with extracellular matrix. Mol Cell
Biol. 22:2345–2365. 2002. View Article : Google Scholar
|
|
15
|
Yaka R, Thornton C, Vagts AJ, Phamluong K,
Bonci A and Ron D: NMDA receptor function is regulated by the
inhibitory scaffolding protein, RACK1. Proc Natl Acad Sci USA.
99:5710–5715. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Battaini F, Pascale A, Paoletti R and
Govoni S: The role of anchoring protein RACK1 in PKC activation in
the ageing rat brain. Trends Neurosci. 20:410–415. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu Y, Mao T, Zhang Y, et al: A crucial
role for RACK1 in the regulation of glucose-stimulated IRE1alpha
activation in pancreatic beta cells. Sci Signal.
3:ra72010.PubMed/NCBI
|
|
18
|
Patterson RL, van Rossum DB, Barrow RK and
Snyder SH: RACK1 binds to inositol 1,4,5-trisphosphate receptors
and mediates Ca2+ release. Proc Natl Acad Sci USA.
101:2328–2332. 2004. View Article : Google Scholar : PubMed/NCBI
|
